Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Brain Neoplasms

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Brain Neoplasms in 1 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castillo, CA1
Albasanz, JL1
Fernández, M1
Martín, M1

Other Studies

1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Brain Neoplasms

ArticleYear
Endogenous expression of adenosine A1, A2 and A3 receptors in rat C6 glioma cells.
    Neurochemical research, 2007, Volume: 32, Issue:6

    Topics: Adenylyl Cyclases; Animals; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Membrane; Flu

2007